Describes the sequence of events that established dialysis encephalopathy as a specific clinical entity and the ultimate discovery of the toxin responsible for both dialysis encephalopathy and fracturing osteomalacia. Correlation between brain calcium and brain aluminum; Alternate methods for the control of serum phosphorus; Use of chelation therapy with deferoxamine in treating dialysis encephalopathy.